CONTACT US   |  (864) 397-5101

Home COVID-19 test brand acquired by Greenville’s Diversified Medical Healthcare

Courtesy GSA Business Report

Diversified Medical Healthcare, a conglomerate of four Greenville health care companies specializing in advanced molecular diagnostics, medical supplies and laboratory equipment, recently acquired the COVID-19 home testing company, RapidRona.

RapidRona test results are delivered straight to the customer in 48 hours or less, according to a news release. 

“We know that COVID-19, unfortunately, is something our population will continue to face,” Kevin Murdock, CEO and founder of Diversified Medical Healthcare, said in the news release. “As recent reports show that the new variants spread faster, cause more severe symptoms, and are causing a decrease in vaccine efficacy, the acquisition of RapidRona is our logical next step in providing necessary solutions for the future of COVID-19. We’re proud to add at-home diagnostic and wellness testing to all that we offer at Diversified Medical Healthcare.”

According to a recent Yale Medicine article cited by the release, the Delta variant is spreading 50% faster than the Alpha variant, which was 50% more contagious than the original strain of COVID-19. 

According to data cited by the press release, “1,271 of 1,528 total new infections were fully vaccinated individuals as were 23 of 27 hospitalizations and 11 out of 17 cases of severe illness.” 

Pivoting from a trend of at-home COVID-19 antigen tests, RapidRona kits provide RT-PCR tests.

“We are excited to see the technology platform in good hands advancing the consumer’s ability to proactively direct their health care from home,” Former RapidRona CEO Heather Mlodinow said in the release.

Diversified Medical Healthcare has reached one of the highest testing capacities in the nation with the capability to process more than 300,000 tests per day, according to the release. They’ve also shifted production to add in-house manufacturing of COVID-19 testing kits and reagents to combat infrastructure limitations and make testing more accessible.

Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more

Tamia Sumpter

Tamia is a driven senior undergraduate Bioengineering student currently enrolled at Clemson University. With a strong foundation in her field, she has honed her skills through hands-on experience in research and development at Eli Lilly & Company. During her time in the ADME department, Tamia contributed significantly by working on siRNAs and their applications in finding In Vitro-In Vivo Correlation (IVIVC). Looking ahead, Tamia has set her sights on a promising career in law. She aspires to specialize in Intellectual Property Law, with a particular focus on serving as in-house counsel for leading medical device or pharmaceutical companies. Her enthusiasm for this role is palpable as she prepares to embark on her legal journey! She is also a proud member of the Omicron Phi chapter of Delta Sigma Theta Sorority, Inc., PEER Mentor for Clemson PEER/WiSE, and currently serves as the President of Clemson Bioengineering Organization (CBO). With her unique blend of scientific knowledge and legal interests, Tamia is poised to make a meaningful impact in the healthcare and life sciences industries.